BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7581829)

  • 1. Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis.
    Evans PJ; Smith C; Mitchinson MJ; Halliwell B
    Free Radic Res; 1995 Nov; 23(5):465-9. PubMed ID: 7581829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein modification: cellular mechanisms.
    Chait A; Heinecke JW
    Curr Opin Lipidol; 1994 Oct; 5(5):365-70. PubMed ID: 7858911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The arterial wall and the atherosclerotic lesion.
    Guyton JR
    Curr Opin Lipidol; 1994 Oct; 5(5):376-81. PubMed ID: 7858913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages.
    Lamb DJ; Mitchinson MJ; Leake DS
    FEBS Lett; 1995 Oct; 374(1):12-6. PubMed ID: 7589497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.
    Leeuwenburgh C; Rasmussen JE; Hsu FF; Mueller DM; Pennathur S; Heinecke JW
    J Biol Chem; 1997 Feb; 272(6):3520-6. PubMed ID: 9013599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry of the arterial wall in developing atherosclerosis.
    Ylă-Herttuala S
    Ann N Y Acad Sci; 1991; 623():40-59. PubMed ID: 2042847
    [No Abstract]   [Full Text] [Related]  

  • 7. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture.
    Bennett MR
    Cardiovasc Res; 1999 Feb; 41(2):361-8. PubMed ID: 10341835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions.
    Smith C; Mitchinson MJ; Aruoma OI; Halliwell B
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):901-5. PubMed ID: 1329721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL.
    Lynch SM; Frei B
    J Biol Chem; 1995 Mar; 270(10):5158-63. PubMed ID: 7890625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of glycation in atherogenesis.
    Pamplona R; Bellmunt MJ; Portero M; Prat J
    Med Hypotheses; 1993 Mar; 40(3):174-81. PubMed ID: 8502197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.
    Heinecke JW
    Curr Opin Lipidol; 1997 Oct; 8(5):268-74. PubMed ID: 9335950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E oxidation in human atherosclerotic lesions.
    Terentis AC; Thomas SR; Burr JA; Liebler DC; Stocker R
    Circ Res; 2002 Feb; 90(3):333-9. PubMed ID: 11861423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-smooth muscle cell interactions during atherosclerosis.
    Hajjar DP; Salisbury BG
    Pathol Immunopathol Res; 1986; 5(6):437-54. PubMed ID: 3039483
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of oxidized lipoproteins in atherogenesis.
    Berliner JA; Heinecke JW
    Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerosis: its cellular manifestations and the mechanisms of the development of the disease in human arteries].
    Smirnov VN; Repin VS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(2):13-31. PubMed ID: 2998415
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
    Yuan XM; Anders WL; Olsson AG; Brunk UT
    Atherosclerosis; 1996 Jul; 124(1):61-73. PubMed ID: 8800494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima.
    Leeuwenburgh C; Hardy MM; Hazen SL; Wagner P; Oh-ishi S; Steinbrecher UP; Heinecke JW
    J Biol Chem; 1997 Jan; 272(3):1433-6. PubMed ID: 8999808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the oxidative modification of LDL by nitecapone.
    Pentikäinen MO; Lindstedt KA; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):740-7. PubMed ID: 7773727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.